Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $716.04 million. The enterprise value is $479.14 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 127.86 million shares outstanding. The number of shares has decreased by -2.85% in one year.
| Current Share Class | 127.86M |
| Shares Outstanding | 127.86M |
| Shares Change (YoY) | -2.85% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 9.32% |
| Owned by Institutions (%) | 52.30% |
| Float | 102.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.64 |
| Forward PS | 3.43 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.17 |
| Quick Ratio | 4.30 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.13 |
Financial Efficiency
Return on equity (ROE) is -3.36% and return on invested capital (ROIC) is -5.35%.
| Return on Equity (ROE) | -3.36% |
| Return on Assets (ROA) | -4.36% |
| Return on Invested Capital (ROIC) | -5.35% |
| Return on Capital Employed (ROCE) | -8.20% |
| Revenue Per Employee | $303,747 |
| Profits Per Employee | -$19,784 |
| Employee Count | 648 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.85 |
Taxes
| Income Tax | -2.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.29% in the last 52 weeks. The beta is 1.33, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -16.29% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 3.89 |
| Relative Strength Index (RSI) | 64.41 |
| Average Volume (20 Days) | 1,867,051 |
Short Selling Information
The latest short interest is 6.40 million, so 5.00% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 6.28M |
| Short % of Shares Out | 5.00% |
| Short % of Float | 6.25% |
| Short Ratio (days to cover) | 9.33 |
Income Statement
In the last 12 months, CTKB had revenue of $196.83 million and -$12.82 million in losses. Loss per share was -$0.11.
| Revenue | 196.83M |
| Gross Profit | 105.23M |
| Operating Income | -34.40M |
| Pretax Income | -15.49M |
| Net Income | -12.82M |
| EBITDA | -26.87M |
| EBIT | -34.40M |
| Loss Per Share | -$0.11 |
Full Income StatementBalance Sheet
The company has $261.73 million in cash and $24.83 million in debt, giving a net cash position of $236.91 million or $1.85 per share.
| Cash & Cash Equivalents | 261.73M |
| Total Debt | 24.83M |
| Net Cash | 236.91M |
| Net Cash Per Share | $1.85 |
| Equity (Book Value) | 378.57M |
| Book Value Per Share | 2.96 |
| Working Capital | 313.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.92 million and capital expenditures -$3.98 million, giving a free cash flow of -$5.90 million.
| Operating Cash Flow | -1.92M |
| Capital Expenditures | -3.98M |
| Free Cash Flow | -5.90M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 53.46%, with operating and profit margins of -17.48% and -6.51%.
| Gross Margin | 53.46% |
| Operating Margin | -17.48% |
| Pretax Margin | -7.87% |
| Profit Margin | -6.51% |
| EBITDA Margin | -13.65% |
| EBIT Margin | -17.48% |
| FCF Margin | n/a |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.85% |
| Shareholder Yield | 2.85% |
| Earnings Yield | -1.79% |
| FCF Yield | -0.82% |
Analyst Forecast
The average price target for CTKB is $5.88, which is 5.00% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.88 |
| Price Target Difference | 5.00% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 5.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 3.78 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.78 |
| Piotroski F-Score | 3 |
